![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Jacob S.
Publisher: Adis International
ISSN: 0012-6667
Source: Drugs, Vol.64, Iss.11, 2004-01, pp. : 1263-1263
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Colla L. La
Clinical Pharmacokinetics, Vol. 48, Iss. 6, 2009-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bevacizumab and hypertension: a Catch-22?
Reactions Weekly, Vol. 1, Iss. 1292, 2010-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Gene therapy for pulmonary hypertension?
Inpharma, Vol. 1, Iss. 1231, 2000-01 ,pp. :